0001242616-12-000012.txt : 20120529 0001242616-12-000012.hdr.sgml : 20120529 20120529140503 ACCESSION NUMBER: 0001242616-12-000012 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120524 FILED AS OF DATE: 20120529 DATE AS OF CHANGE: 20120529 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HEIDEN WILLIAM K CENTRAL INDEX KEY: 0001214939 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10865 FILM NUMBER: 12873673 MAIL ADDRESS: STREET 1: C/O AMAG PHARMACEUTICALS, INC. STREET 2: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0000792977 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042742593 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 6174983300 MAIL ADDRESS: STREET 1: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MAGNETICS INC DATE OF NAME CHANGE: 19920703 4 1 primary_doc.xml PRIMARY DOCUMENT X0305 4 2012-05-24 0 0000792977 AMAG PHARMACEUTICALS INC. AMAG 0001214939 HEIDEN WILLIAM K C/O AMAG PHARMACEUTICALS, INC. 100 HAYDEN AVENUE LEXINGTON MA 02421 1 1 0 0 President and CEO Common Stock 2012-05-24 4 P 0 5000 A 5000 D Common Stock 2012-05-25 4 P 0 5000 A 10000 D The shares purchased on this date were purchased in multiple transactions. The actual purchase prices range from $13.31-$13.55. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each price. The shares purchased on this date were purchased in multiple transactions. The actual purchase prices range from $13.77-$13.96. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each price. Nancy R. Smith, attorney-in-fact 2012-05-29